This role is the owner of the tactical global marketing plan for the Cell Avidity business unit, developing and then driving the execution of the plan. You will work as the link between the business unit, supporting strategy development and the translation of this strategy into the market. To do this, you will create marketing campaigns, content and tools to impact all parts of the customer journey to support LUMICKS to achieve its strategic and revenue goals.
You will work as part of a multi discipline team, interacting with internal and external stakeholders.
Location: Amsterdam, The Netherlands
What are my tasks & responsibilities?
What about my skills & competencies?
LUMICKS has come to market as the supplier of instruments for dynamic single-molecule and cell avidity research – a rapidly evolving niche in the fundamental biology research field. Our high-performance instruments allow for the investigation into the fundamental cause of disease and potential for drug optimization. With our tools researchers can visualize and quantify the interactions between proteins and DNA in real-time, and perform high-throughput screening of molecular and cell-cell interactions using sound waves.
We offer the chance to be part of an important mission: To improve human health by unlocking dynamic single-molecule and cell avidity analysis. With an ever-increasing adoption of our technologies by leading institutes and biotech’s from all over the world, including UC Berkeley, Max-Planck, Rockefeller University and Takeda Pharmaceuticals, LUMICKS is now expanding its team.
Autonomy, ownership & responsibility
Be the leader of your own projects, and own them like no other. Whether you’re developing software or business, you are responsible for your work and the direction it goes.
With new positions opening up weekly and the company still growing exponentially, there are lots of opportunities to broaden your skill set.
Flat organization & open culture
At LUMICKS engagement is key. We try to align everyone on our dreams and strategies to unlock single-molecule and single-cell research.